OPKO Health, Inc. (OPK)
NASDAQ: OPK · IEX Real-Time Price · USD
1.230
0.00 (0.00%)
At close: Apr 19, 2024, 4:00 PM
1.220
-0.010 (-0.81%)
After-hours: Apr 19, 2024, 7:58 PM EDT
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 3.17, with a low estimate of 1.50 and a high estimate of 5.00. The average target predicts an increase of 157.72% from the current stock price of 1.23.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $1.5 | Buy | Maintains | $1.5 | +21.95% | Apr 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $5 | Buy | Reiterates | $5 | +306.50% | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +143.90% | Feb 28, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $2 → $1.5 | Buy | Maintains | $2 → $1.5 | +21.95% | Feb 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +143.90% | Aug 7, 2023 |
Financial Forecast
Revenue This Year
767.91M
from 863.50M
Decreased by -11.07%
Revenue Next Year
846.46M
from 767.91M
Increased by 10.23%
EPS This Year
-0.37
from -0.25
EPS Next Year
-0.26
from -0.37
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 829.6M | 962.1M | 975.6M |
| Avg | 767.9M | 846.5M | 934.0M |
| Low | 693.8M | 776.2M | 902.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.9% | 25.3% | 15.3% |
| Avg | -11.1% | 10.2% | 10.3% |
| Low | -19.6% | 1.1% | 6.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.29 | -0.02 | 0.05 |
| Avg | -0.37 | -0.26 | -0.05 |
| Low | -0.56 | -0.52 | -0.15 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.